DoD Breast Cancer, Transformative Breast Cancer Consortium Development Award
ID: 354871Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354871
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Transformative Breast Cancer Consortium Development Award, aimed at advancing breast cancer research for military personnel, veterans, and the general public. This grant opportunity seeks to establish multi-institutional research teams that include scientists, clinicians, and breast cancer advocates to generate preliminary data and develop the necessary infrastructure for future full consortium applications. With an estimated total program funding of $160,000 and a maximum award amount of $100,000 for a one-year period, interested applicants must submit a Letter of Intent by September 12, 2024, and full applications by September 26, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524BCRPTBCCDA2-GG.pdf
    The Department of Defense's FY24 Transformative Breast Cancer Consortium Development Award seeks innovative applications to advance breast cancer research, with a total appropriation of $150 million aimed at combatting breast cancer for military personnel, veterans, and the general population. The funding is intended to support the formation of multi-institutional research teams comprising scientists, clinicians, and breast cancer advocates, tasked with generating preliminary data to facilitate future full consortium applications. Eligible applicants include both extramural and intramural organizations, and the maximum funding for each development award is capped at $100,000 for a duration of one year. Key submission dates include a Letter of Intent due by September 12, 2024, and full applications by September 26, 2024. All proposals must address overarching challenges within the breast cancer landscape, such as prevention strategies, treatment efficacy, and understanding metastatic behaviors. Applications will undergo a two-tier review process focusing first on technical merit followed by programmatic relevance, culminating in recommendations for funding based on quality and potential impact. This funding opportunity underscores the government's commitment to fostering collaborative efforts aimed at eradicating breast cancer and improving health outcomes.
    Similar Opportunities
    DoD Breast Cancer, Clinical Research Extension Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Breast Cancer Clinical Research Extension Award, a federal grant aimed at enhancing the impact of breast cancer clinical studies. This grant seeks to extend data collection and analysis from existing clinical trials, focusing on improving patient follow-up and addressing knowledge gaps due to early trial terminations. The program is critical for advancing breast cancer research and ensuring that patient contributions are effectively utilized to save lives. With an estimated total funding of $9.3 million, the award will support one application, with a maximum budget of $5 million for single Principal Investigators or $6 million for those utilizing the Partnering PI option. Interested applicants must submit a pre-application by September 12, 2024, and a full application by September 26, 2024. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Breast Cancer, Breakthrough Award Levels 1 and 2
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY2024 Breast Cancer Research Program (BCRP) Breakthrough Award Levels 1 and 2 to support innovative and impactful research aimed at advancing breast cancer prevention, diagnosis, and treatment. This funding opportunity encourages high-risk, high-reward research, with Level 1 focusing on early-stage ideas without the need for preliminary data, while Level 2 requires substantial preliminary data to validate clinical relevance. The program emphasizes collaboration between military and civilian institutions to enhance breast cancer research efforts, with an estimated total funding of $12.6 million available for approximately eight awards. Interested applicants must submit a pre-application through the Electronic Biomedical Research Application Portal (eBRAP) by September 26, 2024, and can direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award (CSCCA) for Fiscal Year 2024. This grant aims to foster transdisciplinary collaborations among scientists, clinicians, and consumer advocates to address urgent issues in cancer research, specifically targeting at least three distinct cancer areas while integrating diverse scientific methodologies. With an estimated total program funding of $32 million and a single award anticipated, applicants must submit a pre-application followed by a full application upon invitation, with the closing date for submissions set for October 15, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Impact Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Impact Award, aimed at funding high-impact cancer research that benefits Service Members, Veterans, and their families. This grant opportunity seeks to support mature research projects that address critical cancer issues, with a focus on translational or clinical research that demonstrates the potential for significant near-term impact on patient outcomes. With an estimated total program funding of $16 million and the expectation of awarding approximately 10 grants, applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Idea Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Idea Award, a federal grant aimed at supporting innovative and high-risk cancer research relevant to military personnel, Veterans, and their families. This grant encourages proposals that challenge existing paradigms and explore new perspectives in cancer research, specifically excluding incremental advancements or ongoing projects. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a two-year period. Interested applicants must submit a pre-application by June 21, 2024, with full applications due later for those invited to proceed, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Rare Cancers, Resource Community Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Rare Cancers Resource and Community Development Award to support research initiatives aimed at improving outcomes for individuals with rare cancers. This grant opportunity seeks to develop clinical or preclinical datasets and research resources that address significant gaps in rare cancer research, emphasizing collaboration among researchers, patients, and clinicians, with a mandatory inclusion of patient advocates in the project planning and implementation phases. With an estimated total funding of $6.4 million available for up to five awards, each project can receive a maximum of $800,000 over a four-year period. Interested applicants must submit a pre-application followed by a full application, with the submission deadline set for September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Pancreatic Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Pancreatic Cancer Translational Research Partnership Award, aimed at fostering innovative collaborations between clinician investigators and research scientists to advance pancreatic cancer research. This grant supports projects that require equal contributions from both partners, focusing on critical areas such as early detection, supportive care interventions, and drug resistance mechanisms, with an emphasis on translating scientific discoveries into clinical applications. The total funding available for this opportunity is $4.8 million, with individual proposals eligible for up to $750,000, and the application process involves a two-step submission via eBRAP and Grants.gov, with a closing date of October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Translational Research Partnership Award, a federal grant aimed at fostering collaborative research partnerships between clinicians and research scientists to advance kidney cancer treatment and care. This opportunity encourages the development of translational research projects that address significant problems in kidney cancer, requiring partnerships that include one clinician and one research scientist who contribute equally to the research design and execution. With an estimated total program funding of $7.68 million, the program anticipates awarding approximately six grants, each with a maximum budget of $800,000 over a three-year period. Interested applicants must submit a pre-application letter of intent by September 24, 2024, followed by a full application due by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.